Results 221 to 230 of about 234,426 (253)

Effectiveness of Group Medical Visits on Cardiometabolic Outcomes in Adult Patients With Cardiometabolic Diseases: An Umbrella Review

open access: yesLifestyle Medicine, Volume 7, Issue 4, October 2026.
ABSTRACT Background and Objective Rising demand and patient complexity challenge primary health care sustainability, prompting interest in group medical visits (GMVs). Although GMVs have been widely studied, heterogeneous evidence hinders synthesis.
Couturier S.   +10 more
wiley   +1 more source

PCSK9 Inhibitors Reduce Oxidative Stress Biomarkers in Heterozygous Familial Hypercholesterolemia. [PDF]

open access: yesJ Cell Mol Med
Woźniak-Szczepocka A   +5 more
europepmc   +1 more source

Neutrophil Extracellular Traps in Atherosclerosis and Cardiovascular Disease

open access: yesMedComm, Volume 7, Issue 10, October 2026.
NETs as integrated effectors in the atherosclerotic cardiovascular disease continuum. Activated neutrophils release NETs that promote endothelial injury, thrombo‐inflammation, and plaque destabilization throughout atherosclerotic disease progression. Created with BioRender.com.
Ji Zhang   +9 more
wiley   +1 more source

Hypertriglyceridemia: Causes, Consequences, Diagnosis, and Management

open access: yesMedComm, Volume 7, Issue 10, October 2026.
Hypertriglyceridemia (HTG) arises from the interplay between genetic susceptibility and secondary or precipitating factors, leading to dysregulated triglyceride‐rich lipoprotein (TRL) metabolism. Increased TRL production and impaired clearance promote distinct risk phenotypes: accumulation of apolipoprotein B(apoB)‐containing TRL remnants contributes ...
Shanshan Qi   +9 more
wiley   +1 more source

Impact of Early, Delayed, or Interrupted Treatment in Children With Familial Hypercholesterolemia. [PDF]

open access: yesJ Am Coll Cardiol
Huang YL   +13 more
europepmc   +1 more source

Efficacy and Safety of Fruquintinib Plus TAS‐102 in Patients With Previously Treated Metastatic Colorectal Cancer: Results From a Single‐Arm, Multi‐Center, Phase II Study

open access: yesMedComm, Volume 7, Issue 10, October 2026.
This study is the first prospective clinical trial that evaluated the efficacy and safety of fruquintinib combined with TAS‐102 in the later‐line treatment of patients with mCRC. Fruquintinib plus TAS‐102 demonstrated promising efficacy and manageable safety profile in patients with mCRC who had failed at least two standard therapies, supporting its ...
Jianjun Peng   +21 more
wiley   +1 more source

Aortic Stenosis in Homozygous Familial Hypercholesterolemia: The Canadian HoFH Registry. [PDF]

open access: yesJACC Adv
Erzingatzian A   +27 more
europepmc   +1 more source

Homozygous familial hypercholesterolemia, experience with Evinacumab treatment in two Mexican pediatric patients: case report. [PDF]

open access: yesFront Genet
Madriz Prado R   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy